• Exchange: LSE EuropeQS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

IPN:LI

29.510 EUR 0.020 0.07%

As of 10:15:48 ET on 04/17/2014.

Snapshot for Ipsen SA (IPN)

Open: 29.700 Day's Range: 29.440 - 29.830 Volume: 4,211
Previous Close: 29.490 52wk Range: 25.165 - 34.855 1-Yr Rtn: +20.00%

Stock Chart for IPN

No chart data available.
  • IPN:LI 29.545
  • 1D
  • 1M
  • 1Y
29.490
Interactive IPN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IPN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 14.9645
Relative P/E vs. UKX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 1.9720
Est. PEG Ratio 1.5577
Market Cap (M EUR) 2,442.52
Shares Outstanding (M) 82.77
30 Day Average Volume 474
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.71%
Cash Dividend (EUR) 0.8000
Dividend Ex-Date 06/09/2014
5 Year Dividend Growth -
Next Earnings Announcement 08/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IPN

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for IPN

Ipsen SA manufactures and markets a wide range of medical drugs for targeted disease areas including oncology, endocrinology, and neuromuscular disorders.

Marc De GaridelChairman/CEOChristel BoriesDeputy CEO
Susheel SurpalExec VP/CFONathalie JoannesExec VP/General Counsel
More Company Profile & Key Executives for IPN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil